Sales_Sales |
Beijing (Beijing) |
China |
International |
|
Der Umsatz |
15. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Xining (Qinghai Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
15. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
15. Mai 2024 |
Sales_Sales |
Beijing (Beijing) |
China |
International |
|
Der Umsatz |
15. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Xining (Qinghai Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
15. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
15. Mai 2024 |
Sales_Sales |
Beijing (Beijing) |
China |
International |
|
Der Umsatz |
15. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Xining (Qinghai Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
15. Mai 2024 |
Product Manager |
Moscow (City) |
Russische Foed. |
International |
Pharmaceuticals |
Marketing |
15. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
15. Mai 2024 |
Sales_Sales |
Beijing (Beijing) |
China |
International |
|
Der Umsatz |
15. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Xining (Qinghai Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
15. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
15. Mai 2024 |
Sales_Sales |
Beijing (Beijing) |
China |
International |
|
Der Umsatz |
15. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Xining (Qinghai Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
15. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
15. Mai 2024 |
Sales_Sales |
Beijing (Beijing) |
China |
International |
|
Der Umsatz |
15. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Xining (Qinghai Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
15. Mai 2024 |
Associate Director DD&IT IM Data Products |
Barcelona Gran Vía |
Spanien |
CTS |
TT CTS |
|
14. Mai 2024 |
Lead IP Transactions Counsel |
Basel |
Schweiz |
Legal |
S&L |
Legal & Intellectual Property & Compliance |
14. Mai 2024 |
Betriebswerker / Maschinenbediener - Bereich Herstellung (m/w/d) |
Wehr (Novartis Pharma Produktions GmbH) |
Deutschland |
Operations |
Pharmaceuticals |
Technical Operations |
14. Mai 2024 |
Regional Hospital Access Head - East |
Shanghai (Shanghai) |
China |
International |
Pharmaceuticals |
Der Umsatz |
14. Mai 2024 |
Consultant, Commercial Design and Advisory |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Marketing |
14. Mai 2024 |
Medical Lead Rare Diseases |
Bratislava |
Slowakei |
International |
Pharmaceuticals |
Research & Development |
14. Mai 2024 |
QC Specialist II (m/w/d), Schaftenau, Tirol |
Schaftenau |
Österreich |
Operations |
Pharmaceuticals |
Quality |
14. Mai 2024 |
Senior Specialist - Audit Mgmnt Office |
Hyderabad (Office) |
Indien |
Operations |
CTS |
|
14. Mai 2024 |
Snr. Spec. DDIT ISC IES |
Hyderabad (Office) |
Indien |
Operations |
CTS |
|
14. Mai 2024 |
Senior RWE Manager |
Dublin (Novartis Global Service Center (NGSC)) |
Irland |
Operations |
CTS |
Market Access |
14. Mai 2024 |
Senior Analyst Commercial Design & Advisory |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Marketing |
14. Mai 2024 |
Key Account Manager – Oncology Therapy Area |
Dublin (Country President Office (CPO)) |
Irland |
International |
Pharmaceuticals |
Der Umsatz |
14. Mai 2024 |
Quality Assurance Systems and Compliance Expert |
Baarle Nassau |
Niederlande |
Operations |
Pharmaceuticals |
Quality |
14. Mai 2024 |
Dermatology Territory Account Specialist – PALM BEACH – Remote |
Field Sales (USA) |
USA |
US |
Pharmaceuticals |
Der Umsatz |
14. Mai 2024 |
Communication & Patient Advocacy Manager |
New South Wales (NSW) |
Australien |
International |
Pharmaceuticals |
Communications & Public Affairs |
14. Mai 2024 |
Corporate Communications Lead |
New South Wales (NSW) |
Australien |
International |
Pharmaceuticals |
Communications & Public Affairs |
14. Mai 2024 |
Research Scientist – Translational Research / Immunology (80-100%*) |
Basel (City) |
Schweiz |
Biomedical Research |
Pharma Research |
Research & Development |
14. Mai 2024 |
Business Data Migration Expert - Manufacturing |
Hyderabad (Office) |
Indien |
Operations |
CTS |
BD&L & Strategic Planning |
14. Mai 2024 |
Principal RWE Research Analyst |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Research & Development |
14. Mai 2024 |
APPRENTI CHEF DE PRODUIT |
Paris Headquarter (Novartis Pharma S.A.S.) |
Frankreich |
International |
Pharmaceuticals |
|
14. Mai 2024 |
Key Account Manager |
Kemerovo |
Russische Foed. |
International |
Pharmaceuticals |
Der Umsatz |
14. Mai 2024 |
MSL Manager - Hematology |
Shanghai (Shanghai) |
China |
International |
Pharmaceuticals |
Research & Development |
14. Mai 2024 |
(高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
14. Mai 2024 |
Allergy Territory Account Specialist – Charlotte, NC – Remote |
Charlotte, NC |
USA |
US |
CUSTOMER ENGAGEMENT |
Der Umsatz |
13. Mai 2024 |
AS&T Analyst (m/w/d), Schaftenau, Tirol |
Schaftenau |
Österreich |
Operations |
Pharmaceuticals |
Quality |
13. Mai 2024 |
Real World Evidence Team Lead |
Dublin (Novartis Global Service Center (NGSC)) |
Irland |
Operations |
CTS |
Market Access |
13. Mai 2024 |
Senior Specialist Information Security Awareness |
Prague |
Tschechische Republik |
Operations |
CTS |
|
13. Mai 2024 |
Real Estate Lead, Data & Technology |
Prague |
Tschechische Republik |
Operations |
CTS |
Einrichtungen und Verwaltung |
13. Mai 2024 |
LDC Solution Design Manager - Tendering |
Barcelona Gran Vía |
Spanien |
Operations |
CTS |
Marketing |
13. Mai 2024 |
External Partner Management Project Leader RLT |
Basel (City) |
Schweiz |
Operations |
Pharmaceuticals |
Research & Development |
13. Mai 2024 |
Treasury Systems and Integration Manager |
Basel (City) |
Schweiz |
Finance |
Corporate |
Audit und Finanzen |
13. Mai 2024 |
Healthcare partnership manager |
Moscow (City) |
Russische Foed. |
International |
Pharmaceuticals |
Market Access |
13. Mai 2024 |